Delivery Order SPE2DB20D2002-SPE2DB25FL71L
Award Date 8/26/25
Potential Completion Date 8/27/25
Potential Value $7.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $11,086.64 delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 mL pen injectors (0.5 mL), a GLP-1 receptor agonist medication used for weight management. This firm fixed price, non-set-aside contract was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $12,879.01 for Zepbound 5 mg/0.5 mL pen injectors, a GLP-1 receptor agonist medication used for weight management. This firm fixed-price delivery order, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The contract utilizes no set-aside designation, indicating open...
- The Defense Logistics Agency awarded a delivery order valued at $1,928.55 to AmerisourceBergen Drug Corp for ZEPBOUND 2.5 MG/0.5 ML Pen 0.5ML, a GLP-1 receptor agonist medication used for weight management. The contract, awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, was competitively awarded without set-aside designation and carries firm fixed pricing. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens (0.5 mL), a GLP-1 receptor agonist medication used for weight management. This firm fixed price delivery order, valued at $23,538.60, is set to be completed by May 13, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a competitive, non-set-aside delivery order and represents a child...
- The Defense Logistics Agency (DLA) awarded a $1,181.87 delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on May 20, 2025, with completion expected by May 21, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $6,750.31 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,690.13 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on August 18, 2025, with completion targeted for August 19, 2025. This competitive, firm fixed-price delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement running through December 2026. The...
- The Defense Logistics Agency has awarded a delivery order valued at $5,248.48 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors. This firm fixed-price delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a competitively awarded non-set-aside contract. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,085.29 by the Defense Logistics Agency on August 13, 2025, for the supply of Zepbound 15 mg/0.5 mL pens. This firm fixed-price, competitively awarded contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,575.48 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 ml pen (0.5 ml), a GLP-1 receptor agonist medication used for weight management. The contract was awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, and represents a competitively awarded, firm fixed-price transaction with no set-aside designation. The place of performance is AmerisourceBergen's corporate office...